Empagliflozin attenuates doxorubicin-induced cardiotoxicity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Empagliflozin attenuates doxorubicin-induced cardiotoxicity

Published:2023-08-31 Issue:5 Volume:12 Page:998-998
ISSN:2045-4538
Container-title:Toxicology Research
language:en
Short-container-title:

Author:

Barış Veysel Özgür¹²^ORCID,Dinçsoy Adnan Berk²,Gedikli Esra²,Zırh Selim³,Müftüoğlu Sevda³,Erdem Ayşen²

Affiliation:

1. Department of Cardiology, Dr. Ersin Arslan Research and Education Hospital , Gaziantep 27010, Turkey

2. Department of Physiology, Hacettepe University Faculty of Medicine , Ankara 06230, Turkey

3. Department of Histology, Hacettepe University Faculty of Medicine , Ankara 06230, Turkey

Publisher

Oxford University Press (OUP)

Subject

Health, Toxicology and Mutagenesis,Toxicology

Link

https://academic.oup.com/toxres/article-pdf/12/5/998/52669266/tfad071.pdf

Reference3 articles.

1. Empagliflozin attenuates doxorubicin- induced cardiotoxicity by activating AMPK/SIRT-1/PGC-1α- mediated mitochondrial biogenesis;Chen;Toxicol Res,2023

2. Empagliflozin significantly prevents the doxorubicin-induced acute cardiotoxicity via non-antioxidant pathways;Barış;Cardiovasc Toxicol,2021

3. Protective effect of taurine against doxorubicin-induced cardiotoxicity in rats: echocardiographical and histological findings;Barış;Amino Acids,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP